chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Computerised tomogram, Headache, Influenza, Nausea
Clinical narrative: Fever as high at 101.8; Terrible chills; Ache; Headache; Nausea; Felt like i had a bad flu; This is a spontaneous report from a contactable consumer or other non-HCP (patient herself). A 68-year-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- EM9810) intramuscularly in left arm on 06Feb2021 12:30 as dose 1, single and received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- EN6202) intramuscularly in left arm on 27Feb2021 11:45 as dose 2, single (at the age of 68-years-old) for COVID-19 immunization. Vaccination facility type was reported as Clinic. Vaccine was not administered at a military facility. Patient medical history included ongoing allergies (hypersensitivity), ongoing GERD (gastroesophageal reflux disease), heart valve calcification repair from 03Dec2019 and ongoing. The concomitant medications included cetirizine hydrochloride (ZYRTEC ALLERGY) taken for allergy (hypersensitivity) via oral route from an unspecified start date and ongoing, metoprolol tartrate via oral route taken for allergy (hypersensitivity, reported as heart) from an unspecified start date and ongoing, pantoprazole via oral route taken for GERDS (gastroesophageal reflux disease) from an unspecified start date and ongoing, fluticasone propionate (FLONASE ALLERGY RELIEF) via oral route taken for an unspecified indication from an unspecified start date and ongoing.  The patient experienced fever as high at 101.8 degrees (after 9 hours from vaccination), terrible chills, ache, headache, nausea, felt like had a bad flu on an unspecified date in 2021. Patient did not go to ER or Doctor. However, for both shots he had nasty side effects for 48 hours, fever as high as 101.8 degree, terrible chills, aches, headaches for 12 hours, nauseated, felt like he had a bad flu started 8-9 hours after shot. The patient underwent lab tests and procedures which included computerized tomogram with result as computerized tomogram (issues from COVID pneumonia) on 31Dec2020. The outcome of the events was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Fever as high at 101.8; Terrible chills; Ache; Headache; Nausea; Felt like i had a bad flu; This is a spontaneous report from a contactable consumer or other non-HCP (patient herself). A 68-year-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- EM9810) intramuscularly in left arm on 06Feb2021 12:30 as dose 1, single and received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- EN6202) intramuscularly in left arm on 27Feb2021 11:45 as dose 2, single (at the age of 68-years-old) for COVID-19 immunization. Vaccination facility type was reported as Clinic. Vaccine was not administered at a military facility. Patient medical history included ongoing allergies (hypersensitivity), ongoing GERD (gastroesophageal reflux disease), heart valve calcification repair from 03Dec2019 and ongoing. The concomitant medications included cetirizine hydrochloride (ZYRTEC ALLERGY) taken for allergy (hypersensitivity) via oral route from an unspecified start date and ongoing, metoprolol tartrate via oral route taken for allergy (hypersensitivity, reported as heart) from an unspecified start date and ongoing, pantoprazole via oral route taken for GERDS (gastroesophageal reflux disease) from an unspecified start date and ongoing, fluticasone propionate (FLONASE ALLERGY RELIEF) via oral route taken for an unspecified indication from an unspecified start date and ongoing.  The patient experienced fever as high at 101.8 degrees (after 9 hours from vaccination), terrible chills, ache, headache, nausea, felt like had a bad flu on an unspecified date in 2021. Patient did not go to ER or Doctor. However, for both shots he had nasty side effects for 48 hours, fever as high as 101.8 degree, terrible chills, aches, headaches for 12 hours, nauseated, felt like he had a bad flu started 8-9 hours after shot. The patient underwent lab tests and procedures which included computerized tomogram with result as computerized tomogram (issues from COVID pneumonia) on 31Dec2020. The outcome of the events was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia
Clinical narrative: tingling in the toes and then went away.; Woke up the next morning with paresthesia in the left foot; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW 0161) via an unspecified route of administration in the left arm on 18Apr2021 at 18:21 (at the age of 16-year-old) as a single dose for COVID-19 immunisation. The patient has no medical history. The patient  previously received cephalosporin nos (MANUFACTURER UNKNOWN) on an unknown date for an unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021 at 10:00 next day morning of vaccination, the patient woke up with paresthesia in the left foot which lasted for three days. On 22Apr2021 fourth day of vaccination, the symptom lessened to a tingling in the toes and then went away. No therapeutic measures were taken as a result of the events. Since the vaccination the patient had not  been tested for COVID-19. The clinical outcome of the event paresthesia in the left foot  was recovered on an unknown date in Apr2021. The clinical outcome of the event tingling in toes was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal
Clinical narrative: brain fog; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6995) via an unspecified route of administration in the left arm on 23Apr2021 at 10:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included premenstrual dysphoria disorder and anxiety. The patient had no known allergies to medications, food, or other products. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 24Apr2021, the patient experienced brain fog for the whole day starting about 24 hours after receiving the vaccine, and the brain fog was gone the next day. The patient had no brain fog on the day she received the vaccine. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event brain fog was resolved on 25Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Chest X-ray, Chest discomfort, Chest pain, Computerised tomogram thorax
Clinical narrative: arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand; arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand; arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand; heart burning; arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand; Ongoing sharp chest pain; chest discomfort/ chest; accelerated heart rate; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 31-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 26Apr2021 10:45 (at the age of 31), (Lot Number: EW0165) as dose 2, single for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 05Apr2021 11:30, (Lot Number: ER8729) as dose 1, single for covid-19 immunisation. On 27Apr2021 the patient experienced, Ongoing sharp chest pain, chest discomfort, chest/heart burning, accelerated heart rate, arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand.  The adverse events resulted in visit to Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient received the treatment for adverse events as NSAIDS. The patient underwent lab tests which included heart rate on 27Apr2021 resulted in accelerated heart rate. Device date was 14May2021. The clinical outcome of the events was not recovered at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Electrocardiogram, Fatigue, Full blood count, Hypoaesthesia, Laboratory test
Clinical narrative: arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand; arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand; arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand; heart burning; arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand; Ongoing sharp chest pain; chest discomfort/ chest; accelerated heart rate; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 31-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 26Apr2021 10:45 (at the age of 31), (Lot Number: EW0165) as dose 2, single for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 05Apr2021 11:30, (Lot Number: ER8729) as dose 1, single for covid-19 immunisation. On 27Apr2021 the patient experienced, Ongoing sharp chest pain, chest discomfort, chest/heart burning, accelerated heart rate, arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand.  The adverse events resulted in visit to Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient received the treatment for adverse events as NSAIDS. The patient underwent lab tests which included heart rate on 27Apr2021 resulted in accelerated heart rate. Device date was 14May2021. The clinical outcome of the events was not recovered at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Limb discomfort, Pain in jaw, Paraesthesia
Clinical narrative: arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand; arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand; arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand; heart burning; arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand; Ongoing sharp chest pain; chest discomfort/ chest; accelerated heart rate; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 31-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 26Apr2021 10:45 (at the age of 31), (Lot Number: EW0165) as dose 2, single for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 05Apr2021 11:30, (Lot Number: ER8729) as dose 1, single for covid-19 immunisation. On 27Apr2021 the patient experienced, Ongoing sharp chest pain, chest discomfort, chest/heart burning, accelerated heart rate, arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand.  The adverse events resulted in visit to Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient received the treatment for adverse events as NSAIDS. The patient underwent lab tests which included heart rate on 27Apr2021 resulted in accelerated heart rate. Device date was 14May2021. The clinical outcome of the events was not recovered at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest discomfort, Chest pain, Dyspepsia, Heart rate, Heart rate increased
Clinical narrative: arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand; arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand; arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand; heart burning; arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand; Ongoing sharp chest pain; chest discomfort/ chest; accelerated heart rate; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 31-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 26Apr2021 10:45 (at the age of 31), (Lot Number: EW0165) as dose 2, single for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 05Apr2021 11:30, (Lot Number: ER8729) as dose 1, single for covid-19 immunisation. On 27Apr2021 the patient experienced, Ongoing sharp chest pain, chest discomfort, chest/heart burning, accelerated heart rate, arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand.  The adverse events resulted in visit to Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient received the treatment for adverse events as NSAIDS. The patient underwent lab tests which included heart rate on 27Apr2021 resulted in accelerated heart rate. Device date was 14May2021. The clinical outcome of the events was not recovered at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia, Limb discomfort, Pain in extremity, Paraesthesia
Clinical narrative: arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand; arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand; arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand; heart burning; arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand; Ongoing sharp chest pain; chest discomfort/ chest; accelerated heart rate; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 31-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 26Apr2021 10:45 (at the age of 31), (Lot Number: EW0165) as dose 2, single for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 05Apr2021 11:30, (Lot Number: ER8729) as dose 1, single for covid-19 immunisation. On 27Apr2021 the patient experienced, Ongoing sharp chest pain, chest discomfort, chest/heart burning, accelerated heart rate, arm numbness, tingling/pins & needles in arm, arm pain, arm falls asleep at night, pain in hand.  The adverse events resulted in visit to Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient received the treatment for adverse events as NSAIDS. The patient underwent lab tests which included heart rate on 27Apr2021 resulted in accelerated heart rate. Device date was 14May2021. The clinical outcome of the events was not recovered at the time of report.  No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: Rash on right leg at calf.; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Apr2021 at 17:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included carvedilol (MANUFACTURER UNKNOWN),  colecalciferol (VITAMIN D3) and ascorbic acid, pyridoxine hydrochloride, biotin, folic acid, cholecalciferol, cyanocobalamin, riboflavin, Phyto menadione, nicotinamide, retinol acetate, calcium pantothenate, ferrous fumarate, calcium carbonate, thiamine mononitrate, zinc oxide, betacarotene, potassium iodide, copper sulfate, calcium phosphate dihydrate, chromic chloride, magnesium oxide heavy, dl-alpha tocopheryl acetate, xantofyl, lycopene, sodium selenate, manganese sulfate monohydrate (CENTRUM FOR WOMEN); all from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 11:00, the patient experienced rash on right leg at calf. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event rash which included treatment with lmpoyz cream twice a day. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event rash on right leg at calf was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: generalized pain; extreme pain in injection arm; fever 100.3; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0161) via an unspecified route of administration in the right arm on 30Apr2021 at 13:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food, or other products. Concomitant medications included diphenhydramine hydrochloride (BENADRYL) and dextromethorphan hydrobromide, doxylamine succinate, ephedrine sulfate, ethanol, paracetamol (NYQUIL); taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via an unspecified route of administration in the right arm on 09Apr2021 at 13:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 16:00, the patient experienced generalized pain, extreme pain in the injection arm and fever 100.3. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events generalized pain, extreme pain in injection arm and fever 100.3 were unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Pain, Pain in extremity, Pyrexia
Clinical narrative: generalized pain; extreme pain in injection arm; fever 100.3; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0161) via an unspecified route of administration in the right arm on 30Apr2021 at 13:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food, or other products. Concomitant medications included diphenhydramine hydrochloride (BENADRYL) and dextromethorphan hydrobromide, doxylamine succinate, ephedrine sulfate, ethanol, paracetamol (NYQUIL); taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6204) via an unspecified route of administration in the right arm on 09Apr2021 at 13:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 16:00, the patient experienced generalized pain, extreme pain in the injection arm and fever 100.3. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events generalized pain, extreme pain in injection arm and fever 100.3 were unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bradykinesia, Dizziness, Feeling abnormal, Gait disturbance
Clinical narrative: Felt like was drugged- Like slow motion; Trouble walking / Trouble get leg foot to step up on a step; Swaying; Became nauseous.; This is a spontaneous report from a contactable consumer. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 09Apr2021 at 13:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included Sjogren's, rheumatoid arthritis, sarcoidosis, Raynaud's, scleroderma, diabetes, Hashimoto disease and allergic to some foods. Concomitant medications included metformin (MANUFACTURER UNKNOWN), prednisone (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), glipizide (MANUFACTURER UNKNOWN) and atorvastatin (MANUFACTURER UNKNOWN); all from an unknown date for an unknown indication, unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 20Mar2021 at 13:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, 3 hours after vaccination, at 16:30 the patient felt like was drugged - like slow motion, trouble walking, swaying, had trouble get leg foot to step up on a step and nauseous. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events of felt like was drugged - like slow motion, trouble walking, swaying, had trouble get leg foot to step up on a step and nauseous were recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bradykinesia, Dizziness, Gait disturbance, Nausea
Clinical narrative: Felt like was drugged- Like slow motion; Trouble walking / Trouble get leg foot to step up on a step; Swaying; Became nauseous.; This is a spontaneous report from a contactable consumer. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 09Apr2021 at 13:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included Sjogren's, rheumatoid arthritis, sarcoidosis, Raynaud's, scleroderma, diabetes, Hashimoto disease and allergic to some foods. Concomitant medications included metformin (MANUFACTURER UNKNOWN), prednisone (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), glipizide (MANUFACTURER UNKNOWN) and atorvastatin (MANUFACTURER UNKNOWN); all from an unknown date for an unknown indication, unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 20Mar2021 at 13:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, 3 hours after vaccination, at 16:30 the patient felt like was drugged - like slow motion, trouble walking, swaying, had trouble get leg foot to step up on a step and nauseous. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events of felt like was drugged - like slow motion, trouble walking, swaying, had trouble get leg foot to step up on a step and nauseous were recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Altered visual depth perception, Dizziness
Clinical narrative: Difficulty with vision; Difficulty with vision - depth perception; This is a spontaneous report from a contactable other healthcare professional, the patient. A 79-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 12:00 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. Medical history included "diabetes 2- flUCOMA". The patient had unspecified allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medications within two weeks of the COVID-19 vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 21Mar2021 at 12:00, the patient experienced difficulty with vision-depth perception. The patient reported that she could not drive. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events difficulty with vision-depth perception was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 79.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Altered visual depth perception, Visual impairment
Clinical narrative: Difficulty with vision; Difficulty with vision - depth perception; This is a spontaneous report from a contactable other healthcare professional, the patient. A 79-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 12:00 (at the age of 79-years-old) as a single dose for COVID-19 immunisation. Medical history included "diabetes 2- flUCOMA". The patient had unspecified allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medications within two weeks of the COVID-19 vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 21Mar2021 at 12:00, the patient experienced difficulty with vision-depth perception. The patient reported that she could not drive. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events difficulty with vision-depth perception was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lip swelling, Swelling face, Swollen tongue
Clinical narrative: swelling of face/ lips / tongue; swelling of face/ lips / tongue; swelling of face/ lips / tongue; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8736) via an unspecified route of administration in the left arm on 21Apr2021 at 13:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to "cillins". Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 19:00, the patient experienced swelling of face, lips and tongue. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling of face/ lips / tongue were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness, beginning 1 week after the second vaccine, mild upon awakening/ today 16 days after second shot dizziness is worse, very mild but constant.; Tired for a couple of days; Soreness at the injection site.; This is a spontaneous report from a contactable other healthcare professional, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration on 15Apr2021 at 18:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included an allergy to sulfa drugs (sulfonamide). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of the COVID-19 vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8750) via an unspecified route of administration on 24Mar2021 at 19:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccination. On 22Apr2021 at 7:00, one week after the second vaccine, the patient experienced dizziness mild, upon awakening. The patient reported that the dizziness was worse, very mild but constant, present even 16 days after the second shot (at the time of reporting). On 22Apr2021 at 07:00, the patient also reported that she had no other side effects except that she was tired for a couple of days and had a little soreness at the injection site. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the events dizziness, tired for a couple of days and soreness at the injection site were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Vaccination site pain
Clinical narrative: Dizziness, beginning 1 week after the second vaccine, mild upon awakening/ today 16 days after second shot dizziness is worse, very mild but constant.; Tired for a couple of days; Soreness at the injection site.; This is a spontaneous report from a contactable other healthcare professional, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration on 15Apr2021 at 18:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included an allergy to sulfa drugs (sulfonamide). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of the COVID-19 vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8750) via an unspecified route of administration on 24Mar2021 at 19:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccination. On 22Apr2021 at 7:00, one week after the second vaccine, the patient experienced dizziness mild, upon awakening. The patient reported that the dizziness was worse, very mild but constant, present even 16 days after the second shot (at the time of reporting). On 22Apr2021 at 07:00, the patient also reported that she had no other side effects except that she was tired for a couple of days and had a little soreness at the injection site. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the events dizziness, tired for a couple of days and soreness at the injection site were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alopecia areata, Blood iron increased, Iron binding capacity unsaturated decreased, Pruritus
Clinical narrative: Alopecia Areata, I've never had it before and there are no cases within my family history.; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 08Mar2021 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) and B-Complex vitamin (MANUFACTURER UNKNOWN) for unknown indication from unknown date. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EM9810) via an unspecified route of administration in the left arm on 08Feb2021 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021, the patient experienced alopecia areata, the patient never had it before and there were no cases within her family history. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included cortisol (MANUFACTURER UNKNOWN) injections on scalp. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event alopecia areata was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alopecia areata
Clinical narrative: Alopecia Areata, I've never had it before and there are no cases within my family history.; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 08Mar2021 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) and B-Complex vitamin (MANUFACTURER UNKNOWN) for unknown indication from unknown date. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EM9810) via an unspecified route of administration in the left arm on 08Feb2021 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021, the patient experienced alopecia areata, the patient never had it before and there were no cases within her family history. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included cortisol (MANUFACTURER UNKNOWN) injections on scalp. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event alopecia areata was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster
Clinical narrative: Developed shingles on right buttocks and thigh; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 17Apr2021 at 09:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The concomitant medication included birth control medication (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Apr2021 at 00:00, the patient developed shingles on right buttocks and thigh. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event and included treatment with Valtex . The clinical outcome of the event  shingles on right buttocks and thigh was resolving as the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 17.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Dizziness, Energy increased, Feeling hot, Inflammation
Clinical narrative: Inflamed sore; Inflamed sore; Itchy rash around the neck; Hives; Heart palpitations; Lightheadedness; Feeling of hotness; Energy rush; Swollen lips; Slight feeling of a swollen tongue; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 15Apr2021 at 11:30 (at the age of 17-year-old) as a single dose for COVID-19 immunisation. Medical history included chronic hives and typical seasonal allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included multivitamin (MANUFACTURER UNKNOWN), colecalciferol (VITAMIN D3), potassium (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C) and cyanocobalamin (VITAMIN B-12) all from unknown dates for unspecified indications and unknown if ongoing. On 15Apr2021 at 11:45, within minutes after the vaccine, the patient experienced hives, heart palpitations, lightheadedness, the feeling of hotness, and an energy rush. All resolved by the time the patient got home. On 20Apr2021, 5 days later, the patient experienced an inflamed sore and itchy rash around the neck ongoing for several days. On an unknown date in 2021, the patient experienced swollen lips and a slight feeling of a swollen tongue on one occasion. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events hives, heart palpitations, lightheadedness, feeling of hotness, and energy rush were resolved on 15Apr2021. The clinical outcome of the events inflamed sore and itchy rash around the neck, swollen lips and slight feeling of a swollen tongue were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 17.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site erythema, Injection site pain, Malaise, Palpitations, Rash
Clinical narrative: Inflamed sore; Inflamed sore; Itchy rash around the neck; Hives; Heart palpitations; Lightheadedness; Feeling of hotness; Energy rush; Swollen lips; Slight feeling of a swollen tongue; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 15Apr2021 at 11:30 (at the age of 17-year-old) as a single dose for COVID-19 immunisation. Medical history included chronic hives and typical seasonal allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included multivitamin (MANUFACTURER UNKNOWN), colecalciferol (VITAMIN D3), potassium (MANUFACTURER UNKNOWN), ascorbic acid (VITAMIN C) and cyanocobalamin (VITAMIN B-12) all from unknown dates for unspecified indications and unknown if ongoing. On 15Apr2021 at 11:45, within minutes after the vaccine, the patient experienced hives, heart palpitations, lightheadedness, the feeling of hotness, and an energy rush. All resolved by the time the patient got home. On 20Apr2021, 5 days later, the patient experienced an inflamed sore and itchy rash around the neck ongoing for several days. On an unknown date in 2021, the patient experienced swollen lips and a slight feeling of a swollen tongue on one occasion. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events hives, heart palpitations, lightheadedness, feeling of hotness, and energy rush were resolved on 15Apr2021. The clinical outcome of the events inflamed sore and itchy rash around the neck, swollen lips and slight feeling of a swollen tongue were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.